Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · IEX Real-Time Price · USD
13.19
+0.11 (0.84%)
May 1, 2024, 4:00 PM EDT - Market closed
Takeda Pharmaceutical Employees
Takeda Pharmaceutical Company had 49,095 employees on March 31, 2023. The number of employees increased by 1,748 or 3.69% compared to the previous year.
Employees
49,095
Change (1Y)
1,748
Growth (1Y)
3.69%
Revenue / Employee
$598,858
Profits / Employee
$25,612
Market Cap
41.39B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2023 | 49,095 | 1,748 | 3.69% |
Mar 31, 2022 | 47,347 | 248 | 0.53% |
Mar 31, 2021 | 47,099 | -396 | -0.83% |
Mar 31, 2020 | 47,495 | -2,083 | -4.20% |
Mar 31, 2019 | 49,578 | 22,348 | 82.07% |
Mar 31, 2018 | 27,230 | -2,670 | -8.93% |
Mar 31, 2017 | 29,900 | -1,268 | -4.07% |
Mar 31, 2016 | 31,168 | -160 | -0.51% |
Mar 31, 2015 | 31,328 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
IQVIA Holdings | 87,000 |
Humana | 67,600 |
Centene | 67,000 |
Cencora | 46,000 |
Alcon | 25,315 |
Edwards Lifesciences | 19,800 |
Agilent Technologies | 18,100 |
IDEXX Laboratories | 11,000 |
TAK News
- 5 days ago - Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer - Business Wire
- 8 days ago - Neurocrine Biosciences Reports Positive Phase 2 Data for NBI-1065845 in Adults with Major Depressive Disorder - PRNewsWire
- 9 days ago - Takeda, Astellas and Sumitomo Mitsui Banking Announce Master Agreement to Establish Joint Venture Company for Incubation of Early Drug Discovery Programs - PRNewsWire
- 13 days ago - U.S. FDA Approves Subcutaneous Administration of Takeda's ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn's Disease - Business Wire
- 23 days ago - Takeda Announces New U.S. Corporate Social Responsibility Program Partners to Build Equity through STEM Education and Access to Nutritional Food - Business Wire
- 5 weeks ago - Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAE - PRNewsWire
- 5 weeks ago - Takeda Announces Candidates for Board of Directors at Upcoming Shareholders Meeting - Business Wire
- 5 weeks ago - Takeda Announces Approval of ADZYNMA® Intravenous Injection 1500 (apadamtase alfa /cinaxadamtase alfa) in Japan for Patients with Congenital Thrombotic Thrombocytopenic Purpura (cTTP) - Business Wire